<DOC>
	<DOCNO>NCT01996618</DOCNO>
	<brief_summary>Investigate whether ranolazine , novel anti-anginal agent antiarrhythmic property , role management symptomatic ventricular premature beat .</brief_summary>
	<brief_title>Study Reduce Symptoms Premature Beats With Ranolazine</brief_title>
	<detailed_description>The main objective compare effect ranolazine versus placebo premature ventricular beat ( use 24-hour ambulatory electrocardiographic monitoring ) subject symptomatic palpitation . Subject population consist seventy-two adult subject sex great 1,000 premature ventricular beat initial monitoring .</detailed_description>
	<mesh_term>Premature Birth</mesh_term>
	<mesh_term>Cardiac Complexes , Premature</mesh_term>
	<mesh_term>Ventricular Premature Complexes</mesh_term>
	<mesh_term>Ranolazine</mesh_term>
	<criteria>Subjects male female 18 year old Symptoms palpitation Greater equal 1,000 Ventricular Premature Beats 24hour electrocardiographic monitor Completion consent form prior prerandomization Holter monitor Moderate severe symptomatic heart failure , New York Heart Association Class III/IV Moderate severe symptomatic angina , Canadian Cardiovascular Classification III/IV Moderate severe structural heart disease absence implantable cardiac defibrillator subject would otherwise eligible defibrillator ( e.g . history myocardial infarction leave ventricular ejection fraction le 30 % ) Clinically significant hepatic disease ( cirrhosis chronic hepatitis ) abnormal liver associate enzymes great three time upper limit normal A baseline correct QT interval great equal 500msec history congenital channelopathy ( long QT syndrome , Brugada syndrome ) torsades de pointes . Treatment agent know prolong QTc interval Treatment agent potent moderately potent inhibitor CYP3A , include , limited following : ketoconazole , HIV protease inhibitor ( i.e . ritonavir ) , macrolide antibiotic ( i.e . clarithromycin ) , diltiazem verapamil Females pregnant , plan get pregnant , breast feeding ( females age 55 year previously undergone surgical sterilization procedure serum qualitative pregnancy test ) Thyroid stimulate hormone less 0.27 IU/mL Serum magnesium le 1.5mg/dL Serum potassium le 3.5 mEq/dL great 5.0 mEq/dL Estimated GFR le 30 mL/min</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>Premature Ventricular Beats</keyword>
	<keyword>Premature Heart Beats</keyword>
	<keyword>Ranolazine</keyword>
</DOC>